Pulmonx Corporation (FRA:4NI)

Germany · Delayed Price · Currency is EUR

1.220

+0.040 (3.39%)

Last updated: Feb 23, 2026, 8:22 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Medical Products	83.79M	68.68M	53.66M	48.42M	32.73M
Medical Products Growth	22.01%	27.98%	10.84%	47.91%	0.42%
Total	83.79M	68.68M	53.66M	48.42M	32.73M
Total Growth	22.01%	27.98%	10.84%	47.91%	0.42%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	56.47M	45.92M	32.49M	24.99M	16.19M
United States Growth	22.97%	41.34%	29.99%	54.37%	51.24%
Europe, Middle-East and Africa (EMEA)	22.33M	19.34M	-	-	-
Europe, Middle-East and Africa (EMEA) Growth	15.48%	-	-	-	-
Asia Pacific	4.44M	3.02M	2.87M	3.41M	2.69M
Asia Pacific Growth	46.84%	5.48%	-16.05%	27.06%	-16.73%
Other International	556.00K	399.00K	155.00K	128.00K	49.00K
Other International Growth	39.35%	157.42%	21.09%	161.22%	-83.67%
Europe, Middle-East and Africa (EMEA) Exclu. Germany	-	-	16.16M	-	8.24M
Europe, Middle-East and Africa (EMEA) Exclu. Germany Growth	-	-	-	-	-26.35%
Germany	-	-	2.00M	5.81M	5.56M
Germany Growth	-	-	-65.63%	4.41%	-22.40%
Europe, Middle-East and Africa (EMEA) Exclu. Germany and France	-	-	-	9.72M	-
France	-	-	-	4.36M	-
Total	83.79M	68.68M	53.66M	48.42M	32.73M
Total Growth	22.01%	27.98%	10.84%	47.91%	0.42%

Source: S&P Global Market Intelligence.